We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares end higher on upbeat German data

Wed, 24th Feb 2021 17:04

* German Q4 GDP grows more than expected

* AstraZeneca to deliver fewer-than-expected vaccines to EU

* Sportswear maker Puma drops as lockdowns affect sales

* Norway's Bakkafrost bottoms out STOXX 600
(Updates to market close)

By Shashank Nayar and Ambar Warrick

Feb 24 (Reuters) - European shares rose on Wednesday as
sectors primed to benefit from economic recovery were supported
by strong German growth data, although concerns over a possible
rise in inflation and lofty equity valuations kept gains in
check.

The pan-European STOXX 600 ended 0.5% higher, with
Germany's DAX adding 0.8% as data showed bullish
exports and solid construction activity helped Europe's biggest
economy to grow by a stronger-than-expected 0.3% in the fourth
quarter.

Travel stocks jumped 1.9% to near one-year highs,
leading European sector gains on optimism around major countries
lifting coronavirus-induced lockdowns.

Still, global airline industry body IATA flagged further
headwinds for airlines in 2021.

"The market has fallen recently due to lofty valuations, but
investors are becoming more accepting of the fact that as
European economies slowly reopen and earnings improve, the
current equity valuations could be justified," said Chris
Beauchamp, chief market analyst at IG Group.

The benchmark STOXX 600 has rebounded nearly 50% from its
March 2020 lows, also led by historic stimulus measures, but it
has still far underperformed a 75% jump in the U.S. S&P 500
.

U.S. Federal Reserve Chair Jerome Powell reiterated on
Tuesday that interest rates will remain low despite indications
of rising inflation, assuaging some fears of a sudden tapering
in monetary stimulus.

"While another stimulus package will certainly be welcomed
by market participants, inflation fears are still present,
despite those concerns being downplayed by officials," said
Milan Cutkovic, market analyst at Axi.

"As more countries are planning the reopening of their
economies, the focus could slowly shift back to value stocks."

The rotation out growth-driven stocks was apparent, with the
technology sector losing nearly 4% this week, lagging
all of its regional peers.

In company news, AstraZeneca dipped 0.2% after it
told the European Union that it expects to deliver less than
half the COVID-19 vaccines it was contracted to supply in the
second quarter.

Norwegian salmon farmer Bakkafrost was the
biggest percentage loser on the STOXX 600 for a second session
after it posted a fourth-quarter loss due to the pandemic.

German sportswear company Puma dropped 2.1% after
saying it expects a heavy impact on its results from lockdowns
through the end of the second quarter.

Telecom Italia surged 9.2% after it said profit
and sales should stabilise this year.
(Reporting by Shashank Nayar in Bengaluru; Editing by Saumyadeb
Chakrabarty and Uttaresh.V and Kirsten Donovan)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.